###begin article-title 0
###xml 135 140 <span type="species:ncbi:10090">mouse</span>
Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse
###end article-title 0
###begin p 1
###xml 305 313 305 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 852 860 844 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1119 1127 1107 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1223 1228 1207 1212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1241 1249 1225 1229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1337 1345 1317 1321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1540 1548 1516 1520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1632 1637 1604 1609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1656 1661 1628 1633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1745 1750 1717 1722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 216 221 <span type="species:ncbi:10090">mouse</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
###xml 1128 1133 <span type="species:ncbi:10090">mouse</span>
###xml 1250 1254 <span type="species:ncbi:10090">mice</span>
###xml 1346 1350 <span type="species:ncbi:10090">mice</span>
###xml 1549 1554 <span type="species:ncbi:10090">mouse</span>
###xml 1593 1602 <span type="species:ncbi:10090">nude mice</span>
###xml 1909 1914 <span type="species:ncbi:10090">mouse</span>
Nuclear receptor coactivator [peroxisome proliferator-activated receptor-binding protein (PBP)/mediator subunit 1 (MED1)] is a critical component of the mediator transcription complex. Disruption of this gene in the mouse results in embryonic lethality. Using the PBP/MED1 liver conditional null (PBP/MED1DeltaLiv) mice, we reported that PBP/MED1 is essential for liver regeneration and the peroxisome proliferator-activated receptor alpha ligand Wy-14,643-induced receptor-mediated hepatocarcinogenesis. We now examined the role of PBP/MED1 in genotoxic chemical carcinogen diethylnitrosamine (DEN)-induced and phenobarbital-promoted hepatocarcinogenesis. The carcinogenic process was initiated by a single intraperitoneal injection of DEN at 14 days of age and initiated cells were promoted with phenobarbital (PB) (0.05%) in drinking water. PBP/MED1DeltaLiv mice, killed at 1, 4 and 12 weeks, revealed a striking proliferative response of few residual PBP/MED1-positive hepatocytes that escaped Cre-mediated deletion of PBP/MED1 gene. No proliferative expansion of PBP/MED1 null hepatocytes was noted in the PBP/MED1DeltaLiv mouse livers. Multiple hepatocellular carcinomas (HCCs) developed in the DEN-initiated PBP/MED1fl/fl and PBP/MED1DeltaLiv mice, 1 year after the PB promotion. Of interest is that all HCC developing in PBP/MED1DeltaLiv mice were PBP/MED1 positive. None of the tumors was PBP/MED1 negative implying that hepatocytes deficient in PBP/MED1 are not susceptible to neoplastic conversion. HCC that developed in PBP/MED1DeltaLiv mouse livers were transplantable in athymic nude mice and these maintained PBP/MED1fl/fl genotype. PBP/MED1fl/fl HCC cell line derived from these tumors expressed PBP/MED1 and deletion of PBP/MED1fl/fl allele by adeno-Cre injection into tumors caused necrosis of tumor cells. These results indicate that PBP/MED1 is essential for the development of HCC in the mouse.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 296 297 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 528 529 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 530 531 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 749 750 749 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 751 752 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 842 843 842 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 892 893 892 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 905 906 905 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 1018 1019 1018 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 1337 1338 1337 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 1339 1341 1339 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 1568 1570 1568 1570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 2022 2024 2022 2024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 2025 2027 2025 2027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 2308 2310 2308 2310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 2311 2313 2311 2313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">19</xref>
###xml 2395 2397 2395 2397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 2398 2400 2398 2400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 2410 2412 2410 2412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 2422 2424 2422 2424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 2425 2427 2425 2427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 2462 2464 2462 2464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 2523 2525 2523 2525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 1384 1389 <span type="species:ncbi:10090">mouse</span>
###xml 1530 1535 <span type="species:ncbi:10090">mouse</span>
###xml 1987 1992 <span type="species:ncbi:10090">mouse</span>
###xml 2265 2270 <span type="species:ncbi:10090">mouse</span>
Nuclear receptors and many other regulated transcription factors control a surprisingly diverse array of genes capable of influencing many biological processes (1,2). Transcriptional activation of genes is a complex process, which involves the participation of many transcription coactivators (3-5). These coactivators bind directly to transcription factors and are involved in the remodeling of chromatin structures and/or in bridging transcription factors with RNA polymerase II and the general basal transcription machinery (4-7). Many of these transcription coactivators along with other coregulatory molecules bind singly or as preformed multisubunit protein complexes to an activated transcription factor to enhance target gene transcription (3-6). Since the cloning of the first transcription coactivator steroid receptor coactivator (7) and corepressors nuclear receptor corepressor (8) and SMRT (9), over 300 coactivators/coregulators have been identified with new members still being added to this spectrum (4). This diversity raises issues about the versatility and complexity of the coregulatory molecules in orchestrating transcription and the need to delineate specific functional roles of individual coregulators in embryogenesis, development, differentiation and oncogenesis, as well as energy and xenobiotic metabolism (4,10). Limited studies involving gene knockout mouse models show that some of the coactivators/coregulators are essential for embryonic growth and survival, whereas others are not critical for mouse embryogenesis (reviewed in ref. 10). For example, the disruption of a coactivator gene such as peroxisome proliferated-activated receptor (PPAR)-binding protein, which is also known as thyroid hormone receptor-associated protein (TRAP) 220, vitamin D3 receptor-interacting protein (DRIP) 205 or mediator subunit 1 (MED1), referred to here as peroxisome proliferator-activated receptor-binding protein (PBP)/MED1, results in embryonic lethality in the mouse around gestational day 11.5 (11-15). Likewise, germ-line deletion of coactivator peroxisome proliferator-activated receptor-interacting protein (PRIP) (ASC-2/RAP250/TRBP/NRC/NCoA6) gene and PRIP-interacting protein with methyltransferase domain (PIMT/NCoA6IP) gene in the mouse also results in embryonic lethality (16-19). On the other hand, null mutation of coactivators steroid receptor coactivator (20,21), SRC-2 (22), SRC-3 (23,24), PPAR gamma coactivator 1 alpha (25) or coactivator associated arginine methyl transferase 1 (26) results in viable phenotype with or without overt functional changes.
###end p 3
###begin p 4
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">28</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 290 295 290 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 397 399 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 456 461 452 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 582 584 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 616 621 612 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 690 692 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">28</xref>
###xml 906 908 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 909 911 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 997 1005 985 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1193 1195 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 1290 1292 1266 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">33</xref>
###xml 1366 1368 1342 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 1527 1529 1503 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 1708 1710 1684 1686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 1711 1713 1687 1689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">38</xref>
###xml 1883 1891 1859 1863 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1953 1961 1925 1929 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 2112 2117 2080 2085 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 2373 2375 2341 2343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">39</xref>
###xml 2431 2433 2399 2401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 2596 2601 2564 2569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 1007 1011 <span type="species:ncbi:10090">mice</span>
###xml 1825 1830 <span type="species:ncbi:10090">mouse</span>
###xml 1892 1896 <span type="species:ncbi:10090">mice</span>
###xml 1962 1966 <span type="species:ncbi:10090">mice</span>
###xml 2622 2631 <span type="species:ncbi:10090">nude mice</span>
To analyze the roles of PBP/MED1 and PRIP in adult tissues, we generated mice for conditional gene disruption using the Cre-loxP strategy (27,28). Using the albumin enhancer and promoter-driven Cre recombinase transgene [Alb-Cre] (29) to mediate hepatocyte-specific deletion of the PBP/MED1fl/fl allele, we demonstrated that PBP/MED1 is essential for PPARalpha-regulated gene expression in liver (27). Likewise, hepatocyte-specific deletion of the PBP/MED1fl/fl allele resulted in near abrogation of the induction of constitutive androstane receptor (CAR)-regulated genes in liver (30). In contrast, deletion of PRIPfl/fl allele in liver did not interfere with PPARalpha and CAR signaling (28). The dependence of PPARalpha and CAR-regulated gene transcription on coactivator PBP/MED1, but not on PRIP, attests to the existence of coactivator selectivity in nuclear receptor function at least in the liver (10,31). Furthermore, PBP/MED1 null hepatocytes in PBP/MED1 liver conditional null (PBP/MED1DeltaLiv) mice did not develop hepatocellular carcinoma (HCC) when chronically exposed to a PPARalpha ligand, indicating that PBP/MED1 is essential for this receptor-mediated liver tumorigenesis (32). PPARalpha ligands, such as ciprofibrate and Wy-14,643, are non-genotoxic hepatocarcinogens (33) that differ from classical DNA-damaging mutagenic chemical carcinogens (34). Typically, mutagenic chemicals and or their electrophilic metabolites interact with and damage DNA inducing mutations and initiating the neoplastic change (34). Therefore, it would be of importance to ascertain whether the PBP/MED1 null hepatocytes function as targets for a potent genotoxic carcinogen such as diethylnitrosamine (DEN) (35-38). Here, we used a DEN/phenobarbital (PB) liver tumor-induction protocol to demonstrate that PBP/MED1-deficient mouse hepatocytes fail to develop liver tumors in PBP/MED1DeltaLiv mice. Initiation by DEN, followed by PB promotion in PBP/MED1DeltaLiv mice, resulted in a failure of PBP/MED1 null hepatocytes to undergo proliferation. However, an occasional PBP/MED1 expressing hepatocyte with PBP/MED1fl/fl genotype that escaped Alb-Cre-mediated deletion exhibited enormous proliferative potential and such cells gave rise to liver tumors following DEN initiation and PB promotion. PB exerts liver tumor promoting effects by activating the nuclear receptor CAR (39) and since PBP/MED1 deficiency abrogates CAR function (30), it would appear that disruption of PBP/MED1 gene would have an impact on liver tumor development. Furthermore, we established a transplantable HCC with PBP/MED1fl/fl genotype in athymic nude mice and show that intratumoral injection of Adeno-Cre-mediated deletion of PBP/MED1 allele in tumor cells caused necrosis. These studies suggest PBP/MED1 is essential for development of HCC and required for the proliferative expansion of liver cancers.
###end p 4
###begin title 5
Materials and methods
###end title 5
###begin title 6
###xml 67 75 67 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
Generation of PBP/MED1 conditional null mutation in liver (PBP/MED1DeltaLiv) and treatment with PB and DEN
###end title 6
###begin p 7
###xml 64 72 64 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PBP/MED1</italic>
###xml 72 80 72 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 148 150 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 175 180 171 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 201 205 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP</italic>
###xml 261 267 257 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AlbCre</italic>
###xml 291 299 287 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PBP/MED1</italic>
###xml 299 307 295 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 314 316 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 695 705 687 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 1245 1247 1236 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">37</xref>
###xml 1761 1764 1752 1755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 2309 2314 2300 2305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 2327 2335 2318 2322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:10090">Mice</span>
###xml 231 236 <span type="species:ncbi:10090">mouse</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">Mice</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 997 1002 <span type="species:ncbi:10090">mouse</span>
###xml 1313 1317 <span type="species:ncbi:10090">mice</span>
###xml 1468 1472 <span type="species:ncbi:10090">mice</span>
###xml 1586 1590 <span type="species:ncbi:10090">mice</span>
###xml 2336 2340 <span type="species:ncbi:10090">mice</span>
The homozygous mutant mice lacking the PBP/MED1 in hepatocytes (PBP/MED1DeltaLiv) were generated and bred in our laboratory as described elsewhere (27). Mice carrying PBP/MED1fl/fl (fl, for flanked by LoxP) allele were bred with a mouse containing albumin-Cre (AlbCre) transgene to generate PBP/MED1DeltaLiv mice (29). All the mice used for experiments were maintained in the C57BL/6 background. Mice were housed, under 12 h light-12 h dark cycle, in a pathogen-free animal facility accredited by the Association for the Advancement and Accreditation of Laboratory Animal Care International. They were maintained on standard rodent chow (Teklad #7904; Harlan-Teklad, Indianapolis, IN) and water ad libitum. All the experiments involving PBP/MED1 liver nulls and wild-type mice were carried out using littermates. All animal procedures used in this study were reviewed and preapproved by the Northwestern University Institutional Animal Care and Use Committee. At 14 days postnatal age, the entire mouse litter received a single intraperitoneal injection of the genotoxic tumor initiator DEN (5 mug/g body weight; catalog no. N0756, Sigma, St Louis, MO; dissolved in 0.9% saline) which induces hepatocyte DNA damage through DNA adduct formation (37). Three days following injection of the tumor initiator DEN, the mice were allowed free access to drinking water containing tumor promoter PB (0.05%) until they were killed at specified intervals. Groups of six to seven mice, containing both males and females, were used for the experiments. Polymerase chain reaction (PCR) genotyping of mice was performed using the following primers flanking loxP site 1 in the floxed PBP/MED1 allele; LoxP+: 5'-TCCATCTGACCTGCTGGATGATAA-3' and LoxP-: 5'- GGGTGTGACCCCATAATT-3'. Cre-specific primers used included Cre-F: 5'-AGGTGTAGAGAAGGCACTCAGC-3' and Cre-R: 5'-CTAATCGCCATCTTCCAGCAGG-3'. PCR genotyping of tumor and non-tumor areas in liver were performed using the following primers flanking exons 8-10 in the floxed PBP/MED1 allele: PBPNA: 5'- GGTTATACATACCTTTCTGCTGT-3' and PBPNS: 5'- CCGTACAGTATCAGTCACCAT-3'. These primers were also used for the genotyping of HCC cell lines derived from these tumors. Microdissection was performed to excise 1 x 1 mm tumor and non-tumorous tissue for DNA extraction. Groups of PBP/MED1fl/fl and PBP/MED1DeltaLiv mice were killed at 1, 4, 12 or 52 weeks after DEN injection. At necropsy, terminal body weights, liver weights and liver morphology were evaluated. Livers were examined for the presence of liver tumors and sections of liver, liver tumors and selected samples of lung were fixed in 10% formalin or 4% paraformaldehyde and processed for light microscopic evaluation by three authors (K.M., M.S.R. and J.K.R.) with liver pathology expertise.
###end p 7
###begin title 8
Bromodeoxyuridine labeling, immunohistochemical staining and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling apoptosis assay
###end title 8
###begin p 9
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 802 807 802 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 820 828 820 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 980 987 976 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 1303 1311 1299 1303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 733 738 <span type="species:ncbi:10090">mouse</span>
###xml 829 833 <span type="species:ncbi:10090">mice</span>
###xml 1312 1316 <span type="species:ncbi:10090">mice</span>
To assess cell proliferation, bromodexoyuridine (BrdUrd) (0.5 mg/ml) was administered in drinking water for 3 days and given a single intraperitoneal dose of BrdUrd (100 mg/kg body wt) 2 h before killing (32). Liver and lung slices were fixed in 10% formalin or 4% paraformaldehyde, processed for embedding in paraffin, sectioned and stained with either hematoxylin and eosin or processed for the immunohistochemical localization of PBP/MED1 and BrdUrd or proliferating cell nuclear antigen. The antibodies used were anti-PBP/MED1 (catalog number sc-5334, Santa Cruz Biotechnology, Santa Cruz, CA), anti-BrdUrd (BD Biosciences, San Jose, CA) and anti-PCNA (catalog number sc-25280, Santa Cruz Biotechnology). To measure apoptosis in mouse liver isolated from either untreated or DEN/PB-treated PBP/MED1fl/fl and PBP/MED1DeltaLiv mice, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling staining was performed on liver sections by using the in situ cell death detection kit from Roche Applied Science (Indianapolis, IN) according to the manufacturer's recommendations. Histological analysis and image processing were carried out using a Leica DMRE microscope equipped with Spot digital camera. The volume occupied by large PBP/MED1 positive hepatocytes in PBP/MED1DeltaLiv mice was estimated by using Scion Image software ().
###end p 9
###begin title 10
###xml 22 31 <span type="species:ncbi:10090">nude mice</span>
Tumor implantation in nude mice
###end title 10
###begin p 11
###xml 213 223 213 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 345 353 345 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 548 553 <span type="species:ncbi:10090">mouse</span>
###xml 838 847 <span type="species:ncbi:10090">nude mice</span>
Male athymic (nu/nu) mice, 5-6 weeks of age (Jackson Laboratory, Bar Harbor, ME), were maintained in a pathogen-free environment, according to an institutionally approved animal protocol, and given food and water ad libitum. After 1 week's acclimation, mice were anesthetized with nembutal prior to tumor implantation. Liver tumors from PBP/MED1DeltaLiv mice, harvested at the end of 1 year on DEN initiation and PB promotion, were chopped into 1-2 mm cubes and one piece of tumor tissue was surgically implanted subcutaneously on the back of nude mouse. Transplanted tumors were processed for histopathological evaluation and for PBP/MED1 immunohistochemical staining. To assess the role of PBP/MED1 in tumor cell survival, we injected Adeno (Ad)-Cre-GFP viral particles (Vector Biolabs, Philadelphia, PA) into the tumor transplanted in nude mice and the tumor tissue examined for histological alterations.
###end p 11
###begin title 12
###xml 22 27 22 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 48 53 48 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
Generation of PBP/MED1fl/fl HCC cell lines (MED1fl/flHCC cell line)
###end title 12
###begin p 13
###xml 111 116 111 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 388 393 388 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 410 415 410 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 92 101 <span type="species:ncbi:10090">nude mice</span>
###xml 317 323 <span type="species:ncbi:9913">bovine</span>
To derive a HCC cell line from the PBP/MED1 expressing HCC serially transplanted in athymic nude mice, PBP/MED1fl/fl tumor tissue was dispersed with collagenase or trypsin digestion into single cells or small cell clumps and these were cultured in fresh Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum. Two cell lines are established and designated as PBP/MED1fl/flHCC1 and PBP/MED1fl/flHCC2 cell line.
###end p 13
###begin title 14
Soft agar colony formation assay
###end title 14
###begin p 15
###xml 437 442 437 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 477 478 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 979 995 979 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 114 120 <span type="species:ncbi:9913">bovine</span>
###xml 213 219 <span type="species:ncbi:9913">bovine</span>
###xml 801 804 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 979 995 <span type="species:ncbi:562">Escherichia coli</span>
Tumor cells (300) were suspended in a 1 ml mixture containing 0.35 (wt/vol) agar DMEM supplemented with 10% fetal bovine serum. This mixture was layered on a 1 ml base of 0.7% (wt/vol) agar in DMEM with 10% fetal bovine serum in a six-well plate and maintained in DMEM for 2 weeks. Colonies were grown for 8 days and live pictures were taken on phase contrast microscope. To check the affect of PBP/MED1 deletion in tumor cells, PBP/MED1fl/flHCC cells were infected with 8 x 108 virus particle [Ad/Cre-GFP or Ad/enhanced green fluorescent protein (EGFP)] and 300 cells were inoculated for 2 weeks and pictures were taken. Ad/Cre-GFP was purchased from Vector Biolabs (catalog no. 1700) while Ad/EGFP was generated as follows: coding sequence of EGFP was cloned into NotI and HindIII sites of pShuttle-CMV expression vector (Quantum Biotechnologies, Quebec, Canada). The shuttle vector and AdEASY vector (Quantum Biotechnologies) were linearized using PmeI and cotransformed into Escherichia coli strain BJ5183 for the homologous recombination. Recombinant plasmid Ad/EGFP was selected and Ad/EGFP virus was generated in HEK293A cells as per manufacturer protocol.
###end p 15
###begin title 16
Quantitative PCR analysis
###end title 16
###begin p 17
###xml 212 217 212 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 230 238 230 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 171 180 <span type="species:ncbi:10090">nude mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
Expression level of PBP/MED1 messenger RNA (mRNA) was analyzed by real-time quantitative PCR (qPCR). Total RNA was extracted from transplanted tumor tissues obtained from nude mice and liver samples from PBP/MED1fl/fl and PBP/MED1DeltaLiv mice using TRIzol reagent (Invitrogen, Carlsbad, CA). Complementary DNA was prepared with 2 mug of total RNA using SuperScripttrade mark III First-Strand Synthesis System for RT-PCR (Invitrogen) and qPCR procedure was performed with SYBR Green Supermix (Applied Biosystems, Foster City, CA) and the oligonucleotide for PBP/MED1 (5'-GAGACTCCGCCCACTTACCG-3' and 5'-GGACACTTCAAACTGGAGG-3'), insulin-like growth factor binding protein 1 (5'-TGCACCCGCCACGAGCAC-3' and 5'-GGGCCATCAGGTGGAAGCTGTC-3'), cyclin D (5'- GTGGTGGCTGCGATGCAAGG-3' and 5'-TGTTCCTGGCAGGCACGGAG-3') and cyclin B1 (5'-CCATGGCGCTCAGGGTCACTAG-3' and 5'-CCGGGCTTGGAAGCAGCAG-3'). Each sample was normalized on the basis of its endogenous 18S ribosomal content and performed in triplicate.
###end p 17
###begin title 18
Results
###end title 18
###begin title 19
###xml 68 76 68 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
PBP/MED1 expressing hepatocytes exhibit growth advantage in PBP/MED1DeltaLiv mice during PB promotion
###end title 19
###begin p 20
###xml 193 198 193 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 262 270 262 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 285 287 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 288 290 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 375 383 371 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 509 511 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 662 664 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 818 820 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 271 276 <span type="species:ncbi:10090">mouse</span>
###xml 384 389 <span type="species:ncbi:10090">mouse</span>
Previously, we demonstrated that chronic exposure to Wy-14,643, a non-genotoxic hepatocarcinogen and a potent peroxisome proliferator, results in a rapid and sustained proliferation of PBP/MED1fl/fl hepatocytes that escaped Cre-mediated gene deletion in PBP/MED1DeltaLiv mouse livers (27,32). PBP/MED1-positive hepatocytes are easily discernible in Wy-14,643 treated PBP/MED1DeltaLiv mouse livers because of their large size, reflecting peroxisome proliferation occurring in response to PPARalpha activation (27). All liver tumors that developed in PBP/MED1 null livers expressed PBP/MED1 and no tumor appeared to be derived from PBP/MED1-deficient hepatocytes (32). This led us to conclude that absence of PBP/MED1 abrogates the response to PPARalpha ligand signaling required for liver tumorigenesis with Wy-14,643 (32).
###end p 20
###begin p 21
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">37</xref>
###xml 396 398 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">38</xref>
###xml 457 462 453 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 475 483 471 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 658 666 650 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 820 828 808 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 972 980 960 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 1232 1240 1220 1224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1258 1263 1242 1247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1387 1402 1371 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A and C</xref>
###xml 1457 1472 1441 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B and D</xref>
###xml 1486 1494 1470 1474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1571 1586 1551 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2E and I</xref>
###xml 1777 1785 1757 1761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1800 1815 1776 1791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2F and J</xref>
###xml 1877 1882 1853 1858 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1961 1970 1937 1946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2J</xref>
###xml 2026 2034 2002 2006 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 2190 2211 2162 2183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2G, H, K and L</xref>
###xml 2284 2292 2256 2260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 2343 2351 2311 2319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
###xml 2426 2434 2394 2402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
###xml 2511 2520 2479 2488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2H</xref>
###xml 2522 2531 2490 2499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4H</xref>
###xml 2617 2625 2585 2589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
###xml 525 529 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 834 838 <span type="species:ncbi:10090">mice</span>
###xml 1117 1121 <span type="species:ncbi:10090">mice</span>
###xml 1241 1245 <span type="species:ncbi:10090">mice</span>
###xml 1264 1268 <span type="species:ncbi:10090">mice</span>
###xml 1495 1499 <span type="species:ncbi:10090">mice</span>
###xml 1786 1791 <span type="species:ncbi:10090">mouse</span>
###xml 2293 2297 <span type="species:ncbi:10090">mice</span>
###xml 2626 2631 <span type="species:ncbi:10090">mouse</span>
In the present study, it was decided to ascertain whether PBP/MED1 null hepatocytes function as targets for tumor development following DEN-initiation and PB promotion (35,37). DEN, in contrast to PPARalpha ligand Wy-14,643, is a genotoxic chemical carcinogen and the DEN-initiated hepatocytes are readily promotable when exposed to liver tumor promoter PB, an activator of nuclear receptor CAR (38). In the present study, following DEN initiation, PBP/MED1fl/fl and PBP/MED1DeltaLiv mice were given PB in drinking water and mice were killed at selected intervals to examine changes in the liver. Liver weight:body weight ratio was slightly lower in PBP/MED1DeltaLiv mice at 4 and 12 weeks on PB promotion and by 52 weeks, the ratios were similar and the increase in ratio at this interval is due to liver tumor burden (Figure 1). In mice given PB for 52 weeks without DEN initiation, the liver weight:body weight ratio remained lower compared with DEN-initiated animals (Figure 1). It should be noted that 1 year of PB treatment had similar effect of liver weight:body weight ratio in normal and PBP/MED1 liver null mice and this is attributed to PB accelerated expansion of the residual PBP/MED1 expressing hepatocytes in PBP/MED1DeltaLiv mice. In PBP/MED1fl/fl mice, the histological appearance of liver was unremarkable at 0, 1 and 12 weeks of PB promotion following DEN initiation (Figure 2A and C). All hepatocytes revealed PBP/MED1 nuclear staining (Figure 2B and D). In PBP/MED1DeltaLiv mice, nuclear staining of PBP/MED1 was not present in hepatocytes at 0 day (Figure 2E and I), except for positive staining in a rare hepatocyte that apparently escaped Cre-mediated gene deletion. By 1 week of PB promotion, large hepatocytes begin to emerge in DEN-initiated PBP/MED1DeltaLiv mouse livers (Figure 2F and J) and they revealed PBP/MED1 nuclear staining implying PBPMED1fl/fl genotype of these cells, in the background of PBP/MED1-deficient hepatocytes (Figure 2J). The PBP/MED1 expressing large hepatocytes in PBP/MED1DeltaLiv livers increased in number and began to dominate the liver phenotype in that they formed large expanding colonies between 12 and 52 weeks of PB promotion (Figure 2G, H, K and L). The volume occupied by large PBP/MED1-positive hepatocytes in PBP/MED1DeltaLiv mice was estimated by using Scion Image software (Figure 3). The data on PBP/MED1 expressing large hepatocytes obtained at 52 weeks (Figure 3) represents only the proportion of these cells in non-neoplastic areas (see Figure 2H; Figure 4H). These results indicate that few PBP/MED1 expressing hepatocytes present in PBP/MED1DeltaLiv mouse livers exhibit profound growth advantage in a milieu where the majority of hepatocytes do not express this coactivator.
###end p 21
###begin p 22
###xml 92 97 92 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 110 118 110 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 126 127 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
Liver weight changes. Liver weight:body weight ratio at 0, 1, 4, 12 and 52 weeks in PBP/MED1fl/fl and PBP/MED1DeltaLiv mice (*P < 0.05) initiated with DEN and promoted with PB. The large increase in liver weight at 52 weeks in DEN-initiated mice was due to the presence of liver tumors.
###end p 22
###begin p 23
###xml 52 57 52 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 70 78 70 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 93 98 89 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 100 101 96 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 102 103 98 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 117 125 113 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 127 128 119 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 129 130 121 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</bold>
###xml 447 452 439 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 547 555 539 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 556 561 <span type="species:ncbi:10090">mouse</span>
Sequential histological changes in liver of PBP/MED1fl/fl and PBP/MED1DeltaLiv mice. PBP/MED1fl/fl (A-D) and PBP/MED1DeltaLiv (E-L) mice initiated with DEN were promoted with PB in drinking water and killed after 0 (A, B, E and I), 1 (F and J), 12 (C, D, G and K) and 52 (H and L) weeks. Liver sections were stained with hematoxylin and eosin (A, C and E-H) or processed for immunohistochemical localization of PBP/MED1 (B, D and I-L). In PBP/MED1fl/fl livers, all hepatocyte nuclei are positive for PBP/MED1 (B and D; see boxed in D). In PBP/MED1DeltaLiv mouse livers, large PBP/MED1-positive hepatocytes proliferate and expand in number (see arrows in J and boxed area in H and L). These are distinct from PBP/MED1-deficient small atrophic, relatively basophilic, PBP/MED1-deficient hepatocytes (boxed areas in G and K).
###end p 23
###begin p 24
###xml 103 111 103 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 112 117 <span type="species:ncbi:10090">mouse</span>
Increase in the volume of PBP/MED1-positive large hepatocytes in DEN-initiated and PB promoted PBP/MED1DeltaLiv mouse livers as analyzed by Scion Image. The data obtained at 52 weeks represents only non-tumor areas.
###end p 24
###begin p 25
###xml 40 45 40 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 58 66 58 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 165 170 161 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 172 173 168 169 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 174 175 170 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 189 197 185 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 199 200 191 192 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 201 202 193 194 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 440 445 432 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 595 603 587 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 646 654 634 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 800 808 784 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 204 209 <span type="species:ncbi:10090">mouse</span>
###xml 446 451 <span type="species:ncbi:10090">mouse</span>
###xml 604 609 <span type="species:ncbi:10090">mouse</span>
Hepatocellular proliferation in PBP/MED1fl/fl and PBP/MED1DeltaLiv mouse livers following DEN initiation and PB promotion. Representative illustrations from PBP/MED1fl/fl (A-D) and PBP/MED1DeltaLiv (E-H) mouse livers. Hepatocellular proliferation was assessed by BrdUrd labeling at 0 (A and E), 1 (B and F), 12 (C and G) and 52 (D and H) weeks. BrdUrd incorporation was evaluated by immunohistochemistry. Many nuclei are labeled in PBP/MED1fl/fl mouse livers (B-D) at 1 (see arrows and boxed area in B), 12 (see arrows and boxed areas in C) and 52 (arrows in D) weeks when compared with PBP/MED1DeltaLiv mouse livers (F-H see arrows). In PBP/MED1DeltaLiv livers, BrdUrd labeling was observed only in PBP/MED-positive large hepatocytes (see arrows in F-H). At 52 weeks, the non-tumor areas in PBP/MED1DeltaLiv livers expanding populations of large hepatocytes are seen and PBP/MED1-negative hepatocytes are smaller (see boxed in H).
###end p 25
###begin p 26
###xml 101 109 101 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 210 215 210 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 224 233 224 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 260 268 260 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 283 292 279 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4F</xref>
###xml 345 360 341 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A and E</xref>
###xml 428 433 424 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 491 500 487 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4C</xref>
###xml 514 522 510 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 623 632 615 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4G</xref>
###xml 732 741 724 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4C</xref>
###xml 835 843 827 831 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 904 909 892 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1090 1105 1078 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4D and H</xref>
###xml 1299 1307 1287 1291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 269 274 <span type="species:ncbi:10090">mouse</span>
###xml 523 528 <span type="species:ncbi:10090">mouse</span>
###xml 844 849 <span type="species:ncbi:10090">mouse</span>
###xml 1308 1312 <span type="species:ncbi:10090">mice</span>
Hepatocellular proliferation was evaluated by BrdUrd incorporation and immunohistochemical staining (Figure 4). Significant increase in BrdUrd nuclear staining was observed at 1 week of PB treatment in PBP/MED1fl/fl livers (Figure 4B) as compared with PBP/MED1DeltaLiv mouse livers (Figure 4F), which was similar to that seen in 0 day controls (Figure 4A and E). In 12 week PB promoted livers, the cell proliferation in PBP/MED1fl/fl livers was still higher than in liver conditional nulls (Figure 4C). In PBP/MED1DeltaLiv mouse livers, BrdUrd nuclear staining was mostly confined to large PBP/MED1 expressing hepatocytes (Figure 4G) in comparison with random labeling of hepatocytes throughout the liver lobule in floxed controls (Figure 4C). At 52 weeks of PB promotion, hepatocellular proliferation in non-tumorous areas in PBP/MED1DeltaLiv mouse livers was more than in non-tumorous areas in PBP/MED1fl/fl livers and this increased BrdUrd nuclear staining liver conditional nulls was due to proliferation of large PBP/MED1-positive hepatocytes and not in smaller hepatocyte population (Figure 4D and H). We carried out terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling staining of liver sections because hematoxylin and eosin stained sections of PBP/MED1DeltaLiv mice showed apoptotic alterations involving non-large hepatocyte areas representing PBP/MED1 null cells (not illustrated). It appeared that apoptosis contributed to the progressive reduction in PBP/MED1-deficient hepatocytes and this served as a stimulus for PBP-positive cells to proliferate. On the other hand, proliferation of large PBP/MED1 expressing hepatocytes may exert compressive pressure on smaller PBP/MED1-deleted hepatocytes forcing them to undergo cell death.
###end p 26
###begin title 27
PBP/MED1 is necessary for DEN-induced liver carcinogenesis
###end title 27
###begin p 28
###xml 40 45 40 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 58 66 58 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 358 366 354 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 516 521 506 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 554 562 542 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 570 585 554 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A and B</xref>
###xml 620 625 604 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 638 646 622 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 757 772 737 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5C and E</xref>
###xml 858 873 826 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5D and F</xref>
###xml 929 937 897 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1344 1354 1308 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figures 2L</xref>
###xml 1356 1358 1320 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">4H</xref>
###xml 1363 1371 1327 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">5E and F</xref>
###xml 1419 1427 1383 1387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1570 1575 1530 1535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1683 1692 1643 1652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5D</xref>
###xml 1751 1756 1711 1716 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1769 1777 1729 1733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1796 1807 1752 1763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6A&#8211;C</xref>
###xml 1920 1931 1876 1887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6D&#8211;F</xref>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
###xml 938 942 <span type="species:ncbi:10090">mice</span>
###xml 1028 1032 <span type="species:ncbi:10090">mice</span>
###xml 1172 1176 <span type="species:ncbi:10090">mice</span>
###xml 1428 1432 <span type="species:ncbi:10090">mice</span>
###xml 1576 1581 <span type="species:ncbi:10090">mouse</span>
###xml 1778 1782 <span type="species:ncbi:10090">mice</span>
At 52 weeks, the livers of both PBP/MED1fl/fl and PBP/MED1DeltaLiv mice that were initiated with DEN and promoted with PB revealed multiple grossly visible tumors that were randomly distributed among all liver lobes. Altered hepatic foci and hepatic adenomas were difficult to delineate due to proliferative expansion of hepatocytes, particularly in PBP/MED1DeltaLiv mice. Accordingly, grossly and histologically distinct HCC were evaluated and the HCC load appeared similar in both groups (9.63 +/- 2.69 in PBP/MED1fl/fl versus 9.13 +/- 2.25 in PBP/MED1DeltaLiv mice) (Figure 5A and B). Histologically, in both PBP/MED1fl/fl and PBP/MED1DeltaLiv mice, a majority of liver tumors was well to moderately differentiated HCC generally with trabecular pattern (Figure 5C and E). We examined approximately30 tumors from each group for the expression of PBP/MED1 (Figure 5D and F). Interestingly, all liver tumors developed in PBP/MED1DeltaLiv mice were PBP/MED1 positive, whereas the surrounding non-tumor portions of liver in these mice did not express this coactivator. Genotyping of microdissected non-tumorous areas confirmed PBP/MED1 gene deletion whereas tumors in these mice had intact gene. Large hepatocytes scattered in predominantly smaller PBP/MED1 gene deleted hepatocytes in non-tumorous areas show PBP/MED1-positive nuclear staining (Figures 2L, 4H and 5E and F). None of the tumors that developed in PBP/MED1DeltaLiv mice was PBP/MED1 negative, implying that PBP/MED1 null hepatocytes are resistant to malignant change. As expected, all tumors in the PBP/MED1fl/fl mouse liver expressed this coactivator and all hepatocytes in non-tumor areas were also PBP/MED1 positive (Figure 5D). We found occasional metastasis in lungs of both PBP/MED1fl/fl and PBP/MED1DeltaLiv mice bearing HCC (Figure 6A-C). Immunohistochemical staining revealed the expression of PBP/MED1 in these metastatic tumor cells in the lung (Figure 6D-F).
###end p 28
###begin p 29
###xml 36 41 36 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 54 62 54 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 70 71 66 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 119 120 113 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 182 183 176 177 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 184 185 178 179 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 354 359 348 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 372 380 366 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 452 457 442 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 491 499 481 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 500 505 <span type="species:ncbi:10090">mouse</span>
DEN induced liver tumors in PBP/MED1fl/fl and PBP/MED1DeltaLiv mice. (A) Liver tumor incidence. Data are mean +/- SD. (B) Representative gross photograph of liver from both groups. (C-F) Histological appearance (hematoxylin and eosin staining; C and E) and immunohistochemical staining for PBP/MED1 (D and F). Liver tumors (T) developing in both PBP/MED1fl/fl and PBP/MED1DeltaLiv mice reveal PBP/MED1 nuclear staining. Non-tumor (NT) areas of PBP/MED1fl/fl (see boxed in D) but not PBP/MED1DeltaLiv mouse livers (see boxed in F) showed PBP/MED1 nuclear staining of hepatocytes. PBP/MED1 is labeled as MED1 in panels (A and B).
###end p 29
###begin p 30
###xml 91 96 91 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 98 99 98 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 113 121 113 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 123 124 119 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 129 130 125 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 206 211 202 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 213 214 209 210 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 228 236 224 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 238 239 230 231 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 244 245 236 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
HCC metastasized to lungs. Hematoxylin and eosin staining of lung metastases from PBP/MED1 fl/fl (A) and PBP/MED1DeltaLiv (B and C) mice. PBP/MED1 immunostaining of metastatic tumors in the lung of PBP/MED1fl/fl (D) and PBP/MED1DeltaLiv (E and F) mice.
###end p 30
###begin title 31
###xml 27 35 27 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
HCC implanted from PBP/MED1DeltaLiv mouse into nude mouse reveal PBP/MED1-positive phenotype
###end title 31
###begin p 32
###xml 70 78 70 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 186 201 182 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7A and B</xref>
###xml 319 320 315 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 624 632 620 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 639 648 631 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7B</xref>
###xml 686 691 678 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 708 713 700 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 817 826 809 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7C</xref>
###xml 891 899 883 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7</xref>
###xml 983 988 975 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1001 1009 993 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1016 1024 1004 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7</xref>
###xml 1148 1156 1136 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7</xref>
###xml 1238 1243 1226 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1256 1264 1244 1248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 175 184 <span type="species:ncbi:10090">nude mice</span>
###xml 396 405 <span type="species:ncbi:10090">nude mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 1010 1014 <span type="species:ncbi:10090">mice</span>
###xml 1265 1270 <span type="species:ncbi:10090">mouse</span>
We transplanted small fragments of liver tumors obtained from PBP/MED1DeltaLiv mice following DEN initiation and PB promotion into the anterior or posterior flanks of athymic nude mice (Figure 7A and B). By 4-5 weeks after initial transplantation, tumors appeared in the sites of implantation and these grew to 10-40 mm3 by 50 days. These tumors are being maintained by serial transplantation in nude mice and the sixth passage is now in progress without apparent changes in the histological pattern of tumors. Transplanted tumors revealed typical HCC appearance akin to that of HCC in DEN initiated and PB promoted PBP/MED1DeltaLiv mice (Figure 7B). These transplanted HCC and PBP/MED1fl/flHCC1 and PBP/MED1fl/flHCC2 cell lines derived from these tumors expressed PBP/MED1 prominently in the nucleus of tumor cells (Figure 7C). We confirmed PBP/MED1 expression in transplanted HCC by qPCR (Figure 7). PBP/MED1 mRNA level in tumors was higher than that in the livers of both PBP/MED1fl/fl and PBP/MED1DeltaLiv mice (Figure 7). Furthermore, we analyzed the expression of insulin-like growth factor binding protein 1, cyclin D and cyclin B1 by qPCR (Figure 7). mRNA content of these genes was significantly higher than that seen in PBP/MED1fl/fl and PBP/MED1DeltaLiv mouse livers which is typical characteristic of tumor cells.
###end p 32
###begin p 33
###xml 25 33 25 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 69 70 65 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 130 131 126 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 257 258 253 254 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 297 298 293 294 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 368 373 364 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 510 515 506 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 523 524 519 520 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 529 530 525 526 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 597 602 593 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 770 771 766 767 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1238 1243 1210 1215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1256 1264 1228 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1452 1457 1420 1425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1471 1479 1439 1443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
###xml 1265 1269 <span type="species:ncbi:10090">mice</span>
###xml 1484 1489 <span type="species:ncbi:10090">mouse</span>
###xml 1530 1539 <span type="species:ncbi:10090">nude mice</span>
Liver tumor from PBP/MED1DeltaLiv mouse transplanted in nude mouse. (A) Third generation transplants (in both flanks) are shown. (B) Typical histological pattern of transplanted tumor expressing PBP/MED1 as assessed by immunohistochemical staining. Panels (C) (hematoxylin and eosin stained) and (D) (PBP/MED1 immunohistochemical staining) of third generation PBP/MED1fl/fl HCC transplants following intratumoral injection of adeno-Cre-GFP. Areas of necrosis (N) represent Cre-mediated deletion of the PBP/MED1fl/fl gene. (E and F) Represent soft agar colony formation assay. Treatment of PBP/MED1fl/flHCC cells with adeno-Cre-GFP caused degeneration and reduction of anchorage-independent colony in soft agar (F) compared with control adeno-EGFP-treated controls (E). (G) Genotyping of HCC lines (HCC-1 and HCC-2) were done with the primers flanking exon 8-10 of PBP/MED1 allele to confirm the deletion of floxed DNA. Infection with Ad/Cre-GFP excised floxed region which resulted into the amplification of mutated band of approximately1.5 kb whereas infection with Ad/EGFP has an intact PBP/MED1 gene which could not be amplified due to large size of amplicon (approximately5.2 kb). Liver genomic DNA from wild-type (C57BL6/J), PBP/MED1fl/fl and PBP/MED1DeltaLiv mice were used for control. The bar graph panels on the right show the qPCR expression levels of PBP/MED1, insulin-like growth factor binding protein 1, cyclin D and cyclin B1 in PBP/MED1fl/fl (1), PBP/MED1DeltaLiv (2) mouse livers and liver tumors transplanted in nude mice (3). Standard error bar represents three independent experiments.
###end p 33
###begin title 34
Deletion of PBP/MED1gene in transplanted HCC causes tumor necrosis in vivo and suppresses colony formation in vitro
###end title 34
###begin p 35
###xml 104 106 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 368 373 364 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 458 460 454 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sup>
###xml 584 593 579 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7C</xref>
###xml 645 660 640 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7C and D</xref>
###xml 739 748 734 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7D</xref>
###xml 771 776 766 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 796 801 791 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 898 907 893 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7F</xref>
###xml 952 957 947 952 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 967 976 962 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7E</xref>
###xml 1476 1485 1447 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7G</xref>
###xml 325 334 <span type="species:ncbi:10090">nude mice</span>
The failure of PBP/MED1-deleted hepatocytes to give rise to liver tumors by PPARalpha ligand Wy-14,643 (32), or following initiation by genotoxic carcinogen DEN and promotion by PB as described here, prompted us to explore the possible biological significance of this coactivator in tumor survival. Since HCC transplanted in nude mice express PBP/MED1 and the PBP/MED1fl/fl gene in these cells can be disrupted by adeno-Cre, we injected adeno-Cre-GFP (2 x 1011 virus particles) intratumorally in a volume of 100 mul and the tumor harvested on the third day for histological analysis (Figure 7C). Extensive areas of tumor necrosis were observed (Figure 7C and D) and the viable tumor tissue was immunohistochemically positive for PBP/MED1 (Figure 7D). Deletion of PBP/MED1fl/fl alleles in PBP/MED1fl/flHCC cell lines by adeno-Cre-GFP resulted in marked suppression of colony formation in soft agar (Figure 7F) as compared with cells with intact PBP/MED1fl/fl alleles (Figure 7E), further implying the importance of this coactivator in the maintenance of neoplastic change. PCR-based genotyping confirmed the deletion of floxed PBP/MED1 allele in HCC-1 and HCC-2 cell lines after infection with Ad/Cre-GFP virus resulting into a short band of approximately1.5 kb after the deletion of floxed exons 8-10. However, HCC cell lines infected with Ad/EGFP has intact PBP/MED1 that could not be amplified due to large size of the amplicon (approximately5.2 kb) causing PCR constraint (Figure 7G).
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 75 80 75 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 290 298 290 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 363 368 359 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 825 827 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 828 830 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 1082 1084 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 1085 1087 1069 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
In the present study, we show that hepatocyte-specific deletion of PBP/MED1fl/fl targeted allele with the Alb-Cre recombinase transgene decreases the susceptibility of PBP/MED1-deficient hepatocytes to genotoxic carcinogen DEN-induced and PB promoted hepatocarcinogenesis. In these PBP/MED1DeltaLiv mice, hepatocytes that escaped Cre-mediated deletion of PBP/MED1fl/fl-targeted allele exhibited profound proliferative potential and these cells are responsible for liver tumor development in this DEN-initiation and PB promotion liver tumor model. Accordingly, all liver tumors expressed PBP/MED1 and none were PBP/MED1 negative. Previously, we reported that PBP/MED1-deficient hepatocytes failed to develop liver tumors when chronically exposed to a non-genotoxic hepatocarcinogen that acts by enhancing PPARalpha signaling (27,32). Absence of PBP/MED1 abrogates PPARalpha signaling in hepatocytes and accordingly abolishes the PPARalpha-ligand-induced pleiotropic responses including peroxisome proliferation, induction of fatty acid oxidation enzymes and liver tumor development (27,32). The data presented here extend these observations to demonstrate that PBP/MED1-deficient hepatocytes are also resistant to tumorigenesis initiated by a potent genotoxic hepatocarcinogen DEN and promoted by PB.
###end p 37
###begin p 38
###xml 345 350 345 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 383 391 383 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 624 626 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">40</xref>
###xml 627 629 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">42</xref>
###xml 778 780 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">42</xref>
###xml 781 783 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">43</xref>
###xml 797 805 789 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 882 887 870 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 896 898 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 988 996 976 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1112 1114 1096 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 1326 1331 1310 1315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1452 1460 1436 1440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1755 1763 1735 1739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 1993 1995 1969 1971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">44</xref>
###xml 2224 2226 2200 2202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 2227 2229 2203 2205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 2230 2232 2206 2208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 3137 3139 3113 3115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">38</xref>
###xml 392 397 <span type="species:ncbi:10090">mouse</span>
###xml 806 811 <span type="species:ncbi:10090">mouse</span>
###xml 997 1002 <span type="species:ncbi:10090">mouse</span>
###xml 1461 1466 <span type="species:ncbi:10090">mouse</span>
###xml 1498 1502 <span type="species:ncbi:10090">mice</span>
###xml 1764 1769 <span type="species:ncbi:10090">mouse</span>
###xml 2759 2764 <span type="species:ncbi:10090">mouse</span>
The mechanisms underlying the inability of PBP/MED1-deficient hepatocytes to give rise to HCC in response to DEN-initiation and PB promotion can reside at two or more levels. First, the metabolism of the genotoxic carcinogen DEN, which was used for initiation, could be defective in hepatocytes with PBP/MED1 deficiency as compared with PBP/MED1fl/fl hepatocytes in the same PBP/MED1DeltaLiv mouse liver. Metabolic activation of DEN occurs in liver within hours after administration via cytochrome P450 (CYP)-dependent alpha-hydroxylation and oxidation to form reactive products capable of generating mutagenic DNA adducts (40-42). CYPs involved in DEN metabolism include CYP1A1, CYP1A2, CYP2B1, CYP2B2 and CYP2E1 and several of these are regulated by the nuclear receptor CAR (42,43). In PBP/MED1DeltaLiv mouse liver, the basal mRNA levels of these CYPs were lower than in PBP/MED1fl/fl livers (30). Parenthetically, it should be noted that these genes are also not inducible in PBP/MED1DeltaLiv mouse liver by CAR activators such as PB and the pesticide contaminant 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (30). The diminished basal levels of CYPs may account for a reduction in DEN metabolism and DNA alkylation contributing to lower number of 'initiated' cells among PBP/MED1-deficient cells in comparison with PBP/MED1fl/fl hepatocytes in the same liver. This can explain the absence of liver tumors with PBP/MED1-deficient genotype in PBP/MED1DeltaLiv mouse liver. However, given that the mice received only a single injection of DEN while they were 14 day old, enzyme induction may not play a major role. Future studies on CYP levels and DEN-related DNA adducts may provide insights into the role of DEN metabolism in HCC development in PBP/MED1DeltaLiv mouse liver. Second, it has been suggested that the process of initiation, which follows the primary DNA alkylation reaction, may take several weeks because two or more rounds of cell division are needed to fix the 'initiation' (44). Fixation of critical mutation may not occur in PBP/MED1-deficient hepatocytes because of their diminished ability to undergo cell proliferation and this could account for a possible reduction in the initiated cell population (27,30,32). Third, initiated PBP/MED1-deficient cells may be highly susceptible to apoptotic cell death and extinction. We noted a higher incidence of apoptosis in PBP/MED1-deficient cells and attributed this to compressive pressure on hepatocytes with inherent defect to divide slowly. Fourth, in this DEN-initiation-PB promotion liver carcinogenesis model, promotion of initiated cells is an integral part toward liver tumor development and evidence suggests that this may be defective in PBP/MED1-deficient hepatocytes. Promotion of mouse hepatocarcinogenesis by PB involves the selection of hepatocytes carrying activating mutations and such a population of initiated cells serves as a sensitive target for PB tumor promotion. Available evidence indicates that CAR is the molecular target of promotion by PB and that activation of this nuclear receptor is an essential requirement for liver tumor development (38).
###end p 38
###begin p 39
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">39</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">39</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">43</xref>
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">45</xref>
###xml 499 507 499 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;Liv</sup>
###xml 687 689 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 690 692 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">46</xref>
###xml 693 695 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">47</xref>
###xml 839 841 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 842 844 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">46</xref>
###xml 977 979 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 508 513 <span type="species:ncbi:10090">mouse</span>
The DEN-initiation and PB promotion studies in CAR knockout mice have established that CAR is necessary for liver tumor promotion by PB (39). CAR activation by PB and 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene increases hepatocellular proliferation and upregulates drug-metabolizing enzymes (39,43). For CAR to exert its effects on gene expression in liver, PB and other activators of this receptor have to induce its translocation into hepatocyte nucleus (45). Of interest is studies using PBP/MED1DeltaLiv mouse livers have clearly established that PBP/MED1 is essential for the nuclear translocation of CAR into hepatocytes and for the proper functioning of this xenobiotic receptor (30,46,47). In the absence of this coactivator, CAR remains in the cytoplasm and fails to induce CYP1A2, CYP2B10 and other CAR-regulated genes in liver (30,46). Absence of PBP/MED1 in liver cells results in the abrogation of hypertrophic and hyperplastic influences mediated by CAR ligands (30). DEN is a genotoxic chemical carcinogen capable of generating DNA adducts that contribute to mutational events necessary for initiation. In contrast, carcinogenesis by non-genotoxic mechanisms, for example PPARalpha-and CAR-mediated carcinogenesis, generally involves receptor-mediated cell proliferation and other metabolic events. The DEN-initiated cells can be influenced by a variety of mechanisms that enhance the proliferative capacity of initiated cells. The studies with PBP/MED1 strongly suggest that this coactivator plays a major role in liver tumorigenesis, whether it is genotoxic and non-genotoxic carcinogenesis.
###end p 39
###begin p 40
###xml 204 209 204 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 297 302 297 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 550 556 550 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARBP</italic>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">48</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">49</xref>
###xml 1160 1162 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">50</xref>
###xml 61 70 <span type="species:ncbi:10090">nude mice</span>
###xml 496 505 <span type="species:ncbi:10090">nude mice</span>
###xml 1138 1143 <span type="species:ncbi:9606">human</span>
Finally, we have established a transplantable HCC in athymic nude mice that expresses high levels of insulin-like growth factor binding protein 1, cyclin D and cyclin B1 and show that deletion of PBP/MED1fl/fl allele using adeno-Cre results in tumor cell necrosis. Two HCC cell lines with PBP/MED1fl/fl allele have also been generated and preliminary studies suggest that adeno-Cre-mediated disruption of PBP/MED1 gene in these cells inhibits colony formation in soft agar and tumor formation in nude mice. We have previously reported that PBP/MED1 (PPARBP) gene, which is localized to chromosome 17q12, a region known to contain the oncogene erbB-2/HER-2, is amplified and overexpressed in breast cancer (48). Recently, it has been shown that the loss of this coactivator inhibits prostate cancer cell proliferation and survival (49). The available data indicate that PBP/MED1 is important for cell proliferation and neoplastic growth and the absence of this molecule adversely affects cell growth. In contrast, a recent study shows that downregulation of the expression of this coactivator in fact enhances the tumorigenic phenotype of human melanoma cells (50). It is possible that PBP/MED1 may exert different effects in different tumor cell types. Additional studies are needed to understand the function of PBP/MED1 and other essential coactivators such as PRIP (51) in tumor formation, growth and survival in liver and other types of cancers.
###end p 40
###begin title 41
Funding
###end title 41
###begin p 42
###xml 0 29 0 29 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</funding-source>
###xml 29 33 29 33 <?release-delay 12|0?>
###xml 35 42 35 42 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GM23750</award-id>
###xml 44 52 44 52 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DK083163</award-id>
National Institutes of Health12|0 (GM23750, DK083163 to J.K.R.).
###end p 42
###begin title 43
Abbreviations
###end title 43
###begin p 44
bromodexoyuridine
###end p 44
###begin p 45
constitutive androstane receptor
###end p 45
###begin p 46
cytochrome p450
###end p 46
###begin p 47
diethylnitrosamine
###end p 47
###begin p 48
Dulbecco's modified Eagles medium
###end p 48
###begin p 49
enhanced green fluorescent protein
###end p 49
###begin p 50
hepatocellular carcinoma
###end p 50
###begin p 51
mediator subunit 1
###end p 51
###begin p 52
messenger RNA
###end p 52
###begin p 53
phenobarbital
###end p 53
###begin p 54
peroxisome proliferator-activated receptor-binding protein
###end p 54
###begin p 55
PBP/MED1 liver conditional null
###end p 55
###begin p 56
polymerase chain reaction
###end p 56
###begin p 57
peroxisome proliferator-activated receptor
###end p 57
###begin p 58
peroxisome proliferator-activated receptor interacting protein
###end p 58
###begin p 59
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest Statement:</italic>
Conflict of Interest Statement: None declared.
###end p 59
###begin article-title 60
The nuclear receptor superfamily: the second decade
###end article-title 60
###begin article-title 61
Nuclear receptors: decoding metabolic disease
###end article-title 61
###begin article-title 62
Combinatorial control of gene expression by nuclear receptors and coregulators
###end article-title 62
###begin article-title 63
The expanding cosmos of nuclear receptor coactivators
###end article-title 63
###begin article-title 64
Nuclear receptor coregulators: multiple modes of modification
###end article-title 64
###begin article-title 65
Mediator and the mechanisms of transcriptional activation
###end article-title 65
###begin article-title 66
Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
###end article-title 66
###begin article-title 67
Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor
###end article-title 67
###begin article-title 68
A transcriptional co-repressor that interacts with nuclear hormone receptors
###end article-title 68
###begin article-title 69
Nuclear receptor transcriptional coactivators in development and metabolism
###end article-title 69
###begin article-title 70
Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor
###end article-title 70
###begin article-title 71
The TRAP220 component of a thyroid hormone receptor- associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion
###end article-title 71
###begin article-title 72
Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex
###end article-title 72
###begin article-title 73
Deletion of PBP/PPARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor-binding protein, results in embryonic lethality
###end article-title 73
###begin article-title 74
Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action
###end article-title 74
###begin article-title 75
Deletion of the cancer-amplified coactivator AIB3 results in defective placentation and embryonic lethality
###end article-title 75
###begin article-title 76
Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development
###end article-title 76
###begin article-title 77
Nuclear receptor coactivator/coregulator NCoA6 (NRC) is a pleiotropic coregulator involved in transcription, cell survival, growth and development
###end article-title 77
###begin article-title 78
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction
###end article-title 78
###begin article-title 79
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Partial hormone resistance in mice with disruption of the steroid receptor coactivator -1 (SRC-1) gene
###end article-title 79
###begin article-title 80
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor alpha-regulated gene expression
###end article-title 80
###begin article-title 81
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP
###end article-title 81
###begin article-title 82
Regulation of somatic growth by the p160 coactivator p/CIP
###end article-title 82
###begin article-title 83
The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development
###end article-title 83
###begin article-title 84
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice
###end article-title 84
###begin article-title 85
###xml 135 139 <span type="species:ncbi:10090">mice</span>
Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine mehyltransferase 1-deficient mice
###end article-title 85
###begin article-title 86
Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver
###end article-title 86
###begin article-title 87
###xml 219 224 <span type="species:ncbi:10090">mouse</span>
Transcription coactivator PRIP, the peroxisome proliferator-activating receptor (PPAR)-interacting protein, is redundant for the function of nuclear receptors PPARalpha and CAR, the constitutive androstane receptor, in mouse liver
###end article-title 87
###begin article-title 88
Normal growth and development in the absence of hepatic insulin-like growth factor I
###end article-title 88
###begin article-title 89
Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity
###end article-title 89
###begin article-title 90
Transcription coactivators for peroxisome proliferator-activated receptors
###end article-title 90
###begin article-title 91
Critical role for transcription coactivator peroxisome proliferator-activated receptor PPAR)-binding protein TRAP/220 in liver regeneration and PPARalpha ligand-induced liver tumor development
###end article-title 91
###begin article-title 92
Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens
###end article-title 92
###begin article-title 93
Risk assessment of chemical carcinogens and thresholds
###end article-title 93
###begin article-title 94
###xml 179 183 <span type="species:ncbi:10090">mice</span>
Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotions by Phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/2NCr mice
###end article-title 94
###begin article-title 95
###xml 72 87 <span type="species:ncbi:10090">transgenic mice</span>
Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital
###end article-title 95
###begin article-title 96
Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor
###end article-title 96
###begin article-title 97
Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine-induced hepatocarcinogenesis
###end article-title 97
###begin article-title 98
###xml 127 131 <span type="species:ncbi:10090">mice</span>
The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice
###end article-title 98
###begin article-title 99
N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation
###end article-title 99
###begin article-title 100
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo
###end article-title 100
###begin article-title 101
The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism
###end article-title 101
###begin article-title 102
CAR, driving into the future
###end article-title 102
###begin article-title 103
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Hepatocarcinogenesis in mice with a conditional knockout of the hepatocyte growth factor receptor c-Met
###end article-title 103
###begin article-title 104
Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene
###end article-title 104
###begin article-title 105
###xml 189 194 <span type="species:ncbi:10090">mouse</span>
Peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP) but not PPAR-interacting protein (PRIP) is required for nuclear translocation of constitutive androstane receptor in mouse liver
###end article-title 105
###begin article-title 106
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
Conditional ablation of mediator subunit MED1 (MED1/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis
###end article-title 106
###begin article-title 107
Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer
###end article-title 107
###begin article-title 108
A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression
###end article-title 108
###begin article-title 109
###xml 101 106 <span type="species:ncbi:9606">human</span>
Down-regulation of RB18A/MED1, a cofactor of transcription, triggers strong tumorigenic phenotype of human melanoma cells
###end article-title 109
###begin article-title 110
PRIP promotes tumor formation through enhancing serum-responsive factor-mediated FOS expression
###end article-title 110

